BERGER FRANKLIN M 4
4 · Atea Pharmaceuticals, Inc. · Filed Dec 12, 2024
Insider Transaction Report
Form 4
BERGER FRANKLIN M
Director
Transactions
- Sale
Common Stock
2024-12-10$2.85/sh−359,606$1,023,475→ 451,897 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.955. The Reporting Person undertakes to provide Atea Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.